The mechanisms of synapse loss following tau pathology include both direct and indirect pathways (reviewed by Spires-Jones and Hyman18); however, the severity of synaptic toxicity in the related tauopathy of Alzheimer’s disease appears to be dependent on the stage of disease in preclinical models and in patients post-mortem and in vivo. The gene discussed is MAPT; the disease is Alzheimer disease.